Vol 6 (2021): Continuous Publishing
Review paper
Published online: 2021-11-26

open access

Page views 6019
Article views/downloads 583
Get Citation

Connect on Social Media

Connect on Social Media

Diagnostics and treatment of ocular complications in infantile nephropathic cystinosis

Małgorzata Kowalczyk1, Mario Damiano Toro12, Robert Rejdak1, Przemyslaw Sikora3
Ophthalmol J 2021;6:206-214.

Abstract

Cystinosis, as a rare disease, faces many difficulties with regard to appropriate early diagnostics and treatment. The aim of our study is to present current methods of diagnostics and treatment of ocular complications in an infantile nephropathic type of cystinosis. It is the most severe type, causing many ocular and life-threatening systemic complications. Ocular severe complications are usually due to the presence of an infantile nephropathic form of cystinosis, long-term illness, delayed diagnosis, non-compliance, or inappropriate treatment. Slit-lamp biomicroscopy is a major examination detecting corneal cystine crystals and the main tool in cystinosis diagnostics. Anterior segment optical coherence tomography (AS-OCT) and in vivo confocal microscopy (IVCM) are other helpful devices in monitoring the accumulation of crystals in the cornea.

Article available in PDF format

View PDF Download PDF file

References

  1. Pinxten AM, Hua MT, Simpson J, et al. Clinical Practice: A Proposed Standardized Ophthalmological Assessment for Patients with Cystinosis. Ophthalmol Ther. 2017; 6(1): 93–104.
  2. Flockerzi E, Daas L, Schlötzer-Schrehardt U, et al. Ocular changes in nephropathic cystinosis: The course of the gold-dust. Int Ophthalmol. 2019; 39(6): 1413–1418.
  3. Gahl WA, Kuehl EM, Iwata F, et al. Corneal crystals in nephropathic cystinosis: natural history and treatment with cysteamine eyedrops. Mol Genet Metab. 2000; 71(1-2): 100–120.
  4. Elmonem MA, Veys K, Oliveira Arcolino F, et al. Allogeneic HSCT transfers wild-type cystinosin to nonhematological epithelial cells in cystinosis: First human report. Am J Transplant. 2018; 18(11): 2823–2828.
  5. Elmonem MA, Veys KR, Soliman NA, et al. Cystinosis: a review. Orphanet J Rare Dis. 2016; 11: 47.
  6. Katz B, Melles RB, Schneider JA, et al. Corneal thickness in nephropathic cystinosis. Br J Ophthalmol. 1989; 73(8): 665–668.
  7. Broyer M. Cystinosis. In: Niaudet P. ed. nborn Metabolic Diseases: Diagnosis and Treatment. Springer , Berlin Heidelberg 2012: 617–624.
  8. Gahl WA, Kuehl EM, Iwata F, et al. Corneal crystals in nephropathic cystinosis: natural history and treatment with cysteamine eyedrops. Mol Genet Metab. 2000; 71(1-2): 100–120.
  9. Tsilou E, Zhou M, Gahl W, et al. Ophthalmic manifestations and histopathology of infantile nephropathic cystinosis: report of a case and review of the literature. Surv Ophthalmol. 2007; 52(1): 97–105.
  10. Sonmez K, Ozcan PY. Angle-closure glaucoma in a patient with the nanophthalmos-ocular cystinosis-foveoschisis-pigmentary retinal dystrophy complex. BMC Ophthalmol. 2012; 12: 23.
  11. Tsilou ET, Rubin BI, Reed G, et al. Nephropathic Cystinosis. Posterior Segment Manifestations and Effects of Cysteamine Therapy. Ophthalmology, vol. 113, no. 6, pp. 2006; 113(6): 1002–1009.
  12. Ariceta G, Camacho JA, Fernández-Obispo M, et al. Grupo T-CiS.bcn. Cystinosis in adult and adolescent patients: Recommendations for the comprehensive care of cystinosis. Nefrologia. 2015; 35(3): 304–321.
  13. Martín-Begué N, Alarcón S, Wolley-Dod C, et al. Intracranial Hypertension in Cystinosis Is a Challenge: Experience in a Children's Hospital. JIMD Rep. 2017; 35: 17–22.
  14. Biswas S, Gaviria M, Malheiro L, et al. Latest Clinical Approaches in the Ocular Management of Cystinosis: A Review of Current Practice and Opinion from the Ophthalmology Cystinosis Forum. Ophthalmol Ther. 2018; 7(2): 307–322.
  15. Labbé A, Niaudet P, Loirat C, et al. In vivo confocal microscopy and anterior segment optical coherence tomography analysis of the cornea in nephropathic cystinosis. Ophthalmology. 2009; 116(5): 870–876.
  16. Zhivov A, Stachs O, Kraak R, et al. In Vivo Confocal Microscopy of the Ocular Surface. Ocular Surf. 2006; 4(2): 81–93.
  17. Liang H, Baudouin C, Tahiri Joutei Hassani R, et al. Photophobia and corneal crystal density in nephropathic cystinosis: an in vivo confocal microscopy and anterior-segment optical coherence tomography study. Invest Ophthalmol Vis Sci. 2015; 56(5): 3218–3225.
  18. Liang H, Labbé A, Le Mouhaër J, et al. A New Viscous Cysteamine Eye Drops Treatment for Ophthalmic Cystinosis: An Open-Label Randomized Comparative Phase III Pivotal Study. Invest Ophthalmol Vis Sci. 2017; 58(4): 2275–2283.
  19. Kowalczyk M, Piecyk-Sidor M, Mackiewicz J, et al. Posterior staphyloma in the normal lenght eyeball — a case report. Klin Oczna. 2007; 109(4–6).
  20. Kowalczyk M, Toro MD, Rejdak R, et al. Ophthalmic Evaluation of Diagnosed Cases of Eye Cystinosis: A Tertiary Care Center’s Experience. Diagnostics (Basel). 2020; 10(11): 911.
  21. Al-Hemidan A, Shoughy SS, Kozak I, et al. Efficacy of topical cysteamine in nephropathic cystinosis. Br J Ophthalmol. 2017; 101(9): 1234–1237.
  22. Veys KRP, Besouw MTP, Pinxten AM, et al. Cystinosis: a new perspective. Acta Clin Belg. 2016; 71(3): 131–137.
  23. Biswas S, Sornalingam K. The Ocular Status of Cystinosis Patients Receiving a Hospital Pharmacy-Made Preparation of Cysteamine Eye Drops: A Case Series. Ophthalmol Ther. 2019; 8(1): 125–136.